Clinical Trial Update: A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic

View source ↗

Summary

This completed study evaluated quality of life outcomes in adult patients with severe refractory atopic dermatitis treated with dupilumab in the Czech Republic.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: COMPLETED